Psoriasis is a distressing condition and a cosmetic problem – even people with mild symptoms are affected badly.

It is a chronic disease like B.P and diabetes which cannot be cured, but controlled and clear skin is now a possibility with newer treatment options such as biologicals.

Symptoms of psoriasis emerge on the skin, and while the thick, flaky scales cause discomfort and embarrassment for some people, they can also cause physical pain and intense itching. Over a period of time, psoriasis is associated with an increased risk of developing other health conditions such as psoriatic arthritis (pain and inflammation of the joints), which is estimated to affect around a third of people with psoriasis, as well as cardiovascular disease, diabetes and depression.

Various treatment options are available to treat psoriasis but with limitations related to efficacy and side effects. ~5 out of 10 patients are dissatisfied with the current treatment options. Patients with psoriasis want clear skin. Newer treatment options like biologics represent a step forward in the treatment of psoriasis by allowing more people to better manage the condition. They are the newest and most advanced type of psoriasis treatment. They offer quick clearance and long periods of remission.

Secukinumab has recently been launched in India by Novartis Healthcare Private Limited under the brand name Scapho. Efficacy with this drug is seen as early as 3 weeks and maintained up to 3 years with continuous treatment. This drug signifies an important turning point for psoriasis patients in India, as they can now access a treatment that has the proven ability to offer clear skin.

Partnering with a dermatologist is the best way to find a treatment that can help achieve clear skin in psoriasis.